Answers are grounded in this paper and cite their sources.
The response rarely sustains long among the responders for Herceptin (trastuzumab) monotherapy treatment. It is still poorly understood how Herceptin exerts its mechanism of action and how the acquired resistance to this drug occurs.
No takes yet. Share an insight, caveat, or question.
Gijsen et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: